| Title |
Teprotumumab for the Treatment of Active Thyroid Eye Disease
|
|---|---|
| Published in |
New England Journal of Medicine, January 2020
|
| DOI | 10.1056/nejmoa1910434 |
| Pubmed ID | |
| Authors |
Raymond S Douglas, George J Kahaly, Amy Patel, Saba Sile, Elizabeth H Z Thompson, Renee Perdok, James C Fleming, Brian T Fowler, Claudio Marcocci, Michele Marinò, Alessandro Antonelli, Roger Dailey, Gerald J Harris, Anja Eckstein, Jade Schiffman, Rosa Tang, Christine Nelson, Mario Salvi, Sara Wester, Jeffrey W Sherman, Thomas Vescio, Robert J Holt, Terry J Smith |
X Demographics
The data shown below were collected from the profiles of 160 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 22 | 14% |
| Spain | 13 | 8% |
| United Kingdom | 10 | 6% |
| India | 9 | 6% |
| Mexico | 6 | 4% |
| Japan | 4 | 3% |
| Colombia | 3 | 2% |
| France | 3 | 2% |
| Venezuela, Bolivarian Republic of | 2 | 1% |
| Other | 22 | 14% |
| Unknown | 66 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 114 | 71% |
| Practitioners (doctors, other healthcare professionals) | 27 | 17% |
| Scientists | 19 | 12% |
Mendeley readers
The data shown below were compiled from readership statistics for 223 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 223 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 10% |
| Student > Postgraduate | 18 | 8% |
| Researcher | 17 | 8% |
| Other | 16 | 7% |
| Student > Doctoral Student | 16 | 7% |
| Other | 53 | 24% |
| Unknown | 80 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 40% |
| Biochemistry, Genetics and Molecular Biology | 9 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Social Sciences | 4 | 2% |
| Neuroscience | 3 | 1% |
| Other | 20 | 9% |
| Unknown | 92 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 525. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2024.
All research outputs
#48,912
of 25,843,331 outputs
Outputs from New England Journal of Medicine
#1,637
of 32,710 outputs
Outputs of similar age
#1,211
of 480,261 outputs
Outputs of similar age from New England Journal of Medicine
#39
of 246 outputs
Altmetric has tracked 25,843,331 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,710 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,261 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.